|Bid||0.00 x 0|
|Ask||507.60 x 0|
|Day's Range||505.15 - 515.00|
|52 Week Range||432.70 - 776.90|
|PE Ratio (TTM)||26.96|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
While India’s largest pharmaceutical companies have seen drug approvals in the U.S. slow overall, their research and development spending has been on a run. Not so for Aurobindo Pharma Ltd.Quarter after ...
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08142017.pdf If you would like to receive this newsletter via email, please register ...
The billionaire founder of Sun Pharmaceutical Industries Ltd. pledged that the drugmaker would do better after reporting its first loss in at least 12 years amid regulatory headaches and a weakening market ...